Association of Active and Sedentary Behaviors with Postmenopausal Estrogen Metabolism

Medicine and Science in Sports and Exercise

Volumn 48, Issue 3, 2016, Pages 439-448

  Dallal, Cher M ^a   Brinton, Louise A ^b   Matthews, Charles E ^b   Pfeiffer, Ruth M ^b   Hartman, Terryl J ^c   Lissowska, Jolanta ^d   Falk, Roni T ^b   Garcia Closas, Montserrat ^e   Xu, Xia ^f   Veenstra, Timothy D ^f,g   Gierach, Gretchen L ^b  

^a UNIVERSITY OF MARYLAND   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

^c EMORY UNIVERSITY   (United States)

^d INSTITUTE OF ONCOLOGY   (Poland)

^e INSTITUTE OF CANCER RESEARCH   (United Kingdom)

^f SAIC FREDERICK INC   (United States)

^g C2N Diagnostics   (United States)

Author keywords

ACCELEROMETERS; ESTROGEN METABOLITES; PHYSICAL ACTIVITY; SEDENTARY

Indexed keywords

2-METHOXYESTRADIOL; 4-METHOXYESTRADIOL; ESTRADIOL; ESTRIOL; ESTROGEN; ESTRONE;

ACCELEROMETRY; ADULT; AGED; ANALOGS AND DERIVATIVES; CASE CONTROL STUDY; EXERCISE; FEMALE; HUMAN; METABOLISM; MIDDLE AGED; POLAND; POSTMENOPAUSE; SEDENTARY LIFESTYLE; URINE;

ACCELEROMETRY; ADULT; AGED; CASE-CONTROL STUDIES; ESTRADIOL; ESTRIOL; ESTROGENS; ESTRONE; EXERCISE; FEMALE; HUMANS; MIDDLE AGED; POLAND; POSTMENOPAUSE; SEDENTARY LIFESTYLE;

EID: 84958842262     PISSN: 01959131     EISSN: 15300315     Source Type: Journal    
DOI: 10.1249/MSS.0000000000000790     Document Type: Article

References (40)

1. Atkinson C, Lampe JW, Tworoger SS, Effects of a moderate intensity exercise intervention on estrogen metabolism in postmenopausal women. Cancer Epidemiol Biomarkers Prev. 2004; 13 (5): 868-74.
2. Bentz AT, Schneider CM, Westerlind KC,. The relationship between physical activity and 2-hydroxyestrone, 16alpha-hydroxyestrone, and the 2/16 ratio in premenopausal women (United States). Cancer Causes Control. 2005; 16 (4): 455-61.
3. Bradlow HL, Sepkovic DW, Klug T, Osborne MP,. Application of an improved ELISA assay to the analysis of urinary estrogen metabolites. Steroids. 1998; 63 (7-8): 406-13.
4. Campbell KL, Westerlind KC, Harber VJ, Bell GJ, Mackey JR, Courneya KS,. Effects of aerobic exercise training on estrogen metabolism in premenopausal women: a randomized controlled trial. Cancer Epidemiol Biomarkers Prev. 2007; 16 (4): 731-9.
5. Cavalieri E, Chakravarti D, Guttenplan J, Catechol estrogen quinones as initiators of breast and other human cancers: implications for biomarkers of susceptibility and cancer prevention. Biochim Biophys Acta. 2006; 1766 (1): 63-78.
6. Dallal CM, Brinton LA, Matthews CE, Accelerometer-based measures of active and sedentary behavior in relation to breast cancer risk. Breast Cancer Res Treat. 2012; 134 (3): 1279-90.
7. Dallal CM, Tice JA, Buist DS, Estrogen metabolism and breast cancer risk among postmenopausal women: a case-cohort study within B ∼ FIT. Carcinogenesis. 2014; 35 (2): 346-55.
8. De Cree C, Ball P, Seidlitz B, Van Kranenburg G, Geurten P, Keizer HA,. Responses of catecholestrogen metabolism to acute graded exercise in normal menstruating women before and after training. J Clin Endocrinol Metab. 1997; 82 (10): 3342-8.
9. De Cree C, Van Kranenburg G, Geurten P, Fujimori Y, Keizer HA,. 4-Hydroxycatecholestrogen metabolism responses to exercise and training: possible implications for menstrual cycle irregularities and breast cancer. Fertil Steril. 1997; 67 (3): 505-16.
10. Eliassen AH, Ziegler RG, Rosner B, Reproducibility of fifteen urinary estrogens and estrogen metabolites over a 2-to 3-year period in premenopausal women. Cancer Epidemiol Biomarkers Prev. 2009; 18 (11): 2860-8.
11. Falk RT, Brinton LA, Dorgan JF, Relationship of serum estrogens and estrogen metabolites to postmenopausal breast cancer risk: a nested case-control study. Breast Cancer Res. 2013; 15 (2): R34.
12. Falk RT, Xu X, Keefer L, Veenstra TD, Ziegler RG,. A liquid chromatography-mass spectrometry method for the simultaneous measurement of 15 urinary estrogens and estrogen metabolites: assay reproducibility and interindividual variability. Cancer Epidemiol Biomarkers Prev. 2008; 17 (12): 3411-8.
13. Friedenreich CM,. The role of physical activity in breast cancer etiology. Semin Oncol. 2010; 37 (3): 297-302.
14. Friedenreich CM, Woolcott CG, McTiernan A, Alberta physical activity and breast cancer prevention trial: sex hormone changes in a year-long exercise intervention among postmenopausal women. J Clin Oncol. 2010; 28 (9): 1458-66.
15. Fuhrman BJ, Brinton LA, Pfeiffer RM, Estrogen metabolism and mammographic density in postmenopausal women: a cross-sectional study. Cancer Epidemiol Biomarkers Prev. 2012; 21 (9): 1582-91.
16. Fuhrman BJ, Schairer C, Gail MH, Estrogen metabolism and risk of breast cancer in postmenopausal women. J Natl Cancer Inst. 2012; 104 (4): 326-39.
17. Fuhrman BJ, Xu X, Falk RT, Stability of 15 estrogens and estrogen metabolites in urine samples under processing and storage conditions typically used in epidemiologic studies. Int J Biol Markers. 2010; 25 (4): 185-94.
18. Garcia-Closas M, Brinton LA, Lissowska J, Established breast cancer risk factors by clinically important tumour characteristics. Br J Cancer. 2006; 95 (1): 123-9.
19. Healy GN, Matthews CE, Dunstan DW, Winkler EA, Owen N,. Sedentary time and cardio-metabolic biomarkers in US adults: NHANES 2003-06. Eur Heart J. 2011; 32 (5): 590-7.
20. Lee IM, Shiroma EJ, Lobelo F, Effect of physical inactivity on major non-communicable diseases worldwide: an analysis of burden of disease and life expectancy. Lancet. 2012; 380 (9838): 219-29.
21. Lynch BM,. Sedentary behavior and cancer: a systematic review of the literature and proposed biological mechanisms. Cancer Epidemiol Biomarkers Prev. 2010; 19 (11): 2691-709.
22. Lynch BM, Friedenreich CM, Winkler EA, Associations of objectively assessed physical activity and sedentary time with biomarkers of breast cancer risk in postmenopausal women: findings from NHANES (2003-2006). Breast Cancer Res Treat. 2011; 130 (1): 183-94.
23. Matthews CE,. Calibration of Accelerometer Output for Adults. Med Sci Sports Exerc. 2005; 37 (11): S512-22.
24. Matthews CE, Ainsworth BE, Thompson RW, Bassett DR Jr,. Sources of variance in daily physical activity levels as measured by an accelerometer. Med Sci Sports Exerc. 2002; 34 (8): 1376-81.
25. Matthews CE, Chen KY, Freedson PS, Amount of time spent in sedentary behaviors in the United States, 2003-2004. Am J Epidemiol. 2008; 167 (7): 875-81.
26. Matthews CE, Fortner RT, Xu X, Hankinson SE, Eliassen AH, Ziegler RG,. Association between physical activity and urinary estrogens and estrogen metabolites in premenopausal women. J Clin Endocrinol Metab. 2012; 97 (10): 3724-33.
27. Matthews CE, Fowke JH, Dai Q, Physical activity, body size, and estrogen metabolism in women. Cancer Causes Control. 2004; 15 (5): 473-81.
28. Matthews CE, Freedson PS, Hebert JR, Seasonal variation in household, occupational, and leisure time physical activity: longitudinal analyses from the seasonal variation of blood cholesterol study. Am J Epidemiol. 2001; 153 (2): 172-83.
29. Matthews CE, Keadle SK, Sampson J, Validation of a previous-day recall measure of active and sedentary behaviors. Med Sci Sports Exerc. 2013; 45 (8): 1629-38.
30. McTiernan A, Tworoger SS, Ulrich CM, Effect of exercise on serum estrogens in postmenopausal women: a 12-month randomized clinical trial. Cancer Res. 2004; 64 (8): 2923-8.
31. Mueck AO, Seeger H, Lippert TH,. Estradiol metabolism and malignant disease. Maturitas. 2002; 43 (1): 1-10.
32. Neilson HK, Friedenreich CM, Brockton NT, Millikan RC,. Physical activity and postmenopausal breast cancer: proposed biologic mechanisms and areas for future research. Cancer Epidemiol Biomarkers Prev. 2009; 18 (1): 11-27.
33. Ortiz MC, Sarabia LA, Herrero A,. Robust regression techniques; A useful alternative for the detection of outlier data in chemical analysis. Talanta. 2006; 70 (3): 499-512.
34. Owen N, Sparling PB, Healy GN, Dunstan DW, Matthews CE,. Sedentary behavior: emerging evidence for a new health risk. Mayo Clin Proc. 2010; 85 (12): 1138-41.
35. Smith AJ, Phipps WR, Thomas W, Schmitz KH, Kurzer MS,. The effects of aerobic exercise on estrogen metabolism in healthy premenopausal women. Cancer Epidemiol Biomarkers Prev. 2013; 22 (5): 756-64.
36. Thompson PA, Ambrosone C,. Molecular epidemiology of genetic polymorphisms in estrogen metabolizing enzymes in human breast cancer. J Natl Cancer Inst Monogr. 2000; 27: 125-34.
37. Vainio H, Kaaks R, Bianchini F,. Weight control and physical activity in cancer prevention: international evaluation of the evidence. Eur J Cancer Prev. 2002; 11 (2 Suppl): S94-100.
38. Welk GJ, McClain JJ, Eisenmann JC, Wickel EE,. Field validation of the MTI Actigraph and BodyMedia armband monitor using the IDEEA monitor. Obesity (Silver Spring). 2007; 15 (4): 918-28.
39. Xu X, Keefer LK, Ziegler RG, Veenstra TD,. A liquid chromatography-mass spectrometry method for the quantitative analysis of urinary endogenous estrogen metabolites. Nat Protoc. 2007; 2 (6): 1350-5.
40. Zhu BT, Conney AH,. Functional role of estrogen metabolism in target cells: review and perspectives. Carcinogenesis. 1998; 19 (1): 1-27.